Roderick H. MacLeod - 28 Feb 2022 Form 4 Insider Report for NEVRO CORP

Role
Chief Financial Officer
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Roderick H. MacLeod
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 20:03:44 UTC
Previous filing
16 Jun 2021
Next filing
04 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +18,249 +96% $0.000000 37,330 28 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs will vest on February 28, 2023 and the remainder will vest quarterly thereafter, subject to the Reporting Person's continued service to the issuer.
F2 Includes 35,900 RSUs.